"I think it's nice for [FDA] to see everything operating as one ... it really helps to have everything in one system that we can test the whole system. You don't want to have a system that the components work but when you plug them all together they don't work and that is one of the concerns of the FDA ... what happens when they start communicating together?"

— Howard Zisser, MD, director of clinical research and diabetes technology at the Sansum Diabetes Research Institute, discussing a new system that provides a testing platform, prior to patient trials, to fully verify and validate that an artificial pancreas can efficiently operate in the variety of conditions reflective of a large group of patients with the disease, "New computer system to aid in artificial pancreas development."